|
1. Lee CC, Chang PC, Chuang HY, Chang HY. Recent development of biomarkers on human lead exposure: A review ( in Chinese). IOSH Journal 2000; 8: 345-72. 2. Loghman-Adham M. Renal effects of environmental and occupational lead exposure. Environ Health Perspect 1997; 105(9): 928-39. 3. Staessen JA, Yeoman WB, Fletcher AE, Markowe HL, Marmot MG, Rose G, Semmence A, Shipley M J, Bulpitt C J. Blood lead concentration, renal function, and blood pressure in London civil servants. Br J Ind Med 1990; 47: 442-7. 4. Staessen JA, Lauwerys RR, Buchet JP, Bulpitt CJ, Rondia D, Vanrenterghen Y, Amery A. Impairment of renal function with increasing blood lead concentrations in the general population. N Engl J Med 1992; 327(3): 151-6. 5. Rayton M, Hu H, Sparrow D, Weiss ST. Low-level lead exposure and renal function in the Normative Aging Study. Am J Epidemiol 1994; 140: 821-9. 6. Kim R, Rotnitsky A, Sparrow D, Weiss S, Wager C, Hu H. A longitudinal study of low-level lead exposure and impairment of renal function: the Normative Aging Study. JAMA.1996; 275(15): 1177-81. 7. Li CM, Tyler PC, Furneaux RH, Xu Y, et al. Transition-state abalogs as inhibitors of human and malarial hypoxanthine-guanine phosphoribosyltransferases. Nature Structural Biology. 1999; 6(6): 582-7. 8. Murray RK, Granner DK, Mayes PA, Rodwell VW. Harper’s Biochemistry. Twenty-third edition. 1993. 9. Lin JL, Huang PT. Body lead stores and urate excretion in men with chronic renal disease. J Rheumatol. 1994; 21(4): 705-9 10.Lin JL, Tan DT, Ho HH, Yu CC. Environmental lead exposure and urate excretion in the general population. Am J Med. 2002; 113:563-8. 11.Shadick NA, Kim R, Weiss S, Liang MH, et al. Effect of low level lead exposure on hyperuricemia and gout among middle aged and elderly men: the Normative Aging Study. J Rheumatol. 2000; 27: 1708-12. 12.Landrigan PJ. Toxicity of lead at low dose. Br J Ind Med 1989; 46: 593-6. 13.Hertz-Picciotto I, Croft J. Review of the relation between blood lead and blood pressure. Epidemiol Rev 1993; 15: 352-73. 14.Vaziri ND. Pathogenesis of lead-induced hypertension: role of oxidative stress. J Hypertens 2002; 20(suppl 3): S15-20. 15.Harlan WR, Landis JR, Schmouder RL, et al. Blood lead and blood pressure: relationship in the adolescent and adult US population. JAMA 1985; 253: 530-4. 16.Maheswaran R, Gill JS, Beevers DG. Blood pressure and industrial lead exposure. Am J Epidemiol 1993; 137: 645-53. 17.Hertz-Picciotto I, Croft J. Review of the relation between blood lead and blood pressure. Epidemiol Review. 1993; 15(2): 352-73. 18.Staessen JA, Roels H, Lauwerys RR, Amery A. Low-level lead exposure and blood pressure. Journal of Human Hypertension. 1995; 9(5): 303-28. 19.Hu H, Aro A, Payton M, Korrick S, et al. The relationship of bone and blood lead to hypertension: the Normative Aging Study. JAMA.1996; 275(15): 1171-6. 20.Hubert C, Houot AM, Corvol P, Soubrier F. Structure of the angiotensin I-converting enzyme gene. The Journal of Biological Chemistry. 1991; 266(23): 15377-83. 21.Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acid Res. 1992; 20: 1433. Letter. 22.Rigat B, Hubert C, Francois AG, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990; 86: 1343-6. 23.Barley J, Blackwood A, Miller M, Markandu ND, et al. Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the rennin-angiotensin system in Caucasian and Afro-Caribbean peoples. Journal of Human Hypertension. 1996; 10(1): 31-5. 24.Yoshida K, Ishigami T, Nakazawa I, Ohno A, et al. Association of essential hypertension in elderly Japanese with I/D polymorphism of the angiotensin-converting enzyme(ACE)gene. Journal of Human Genetics. 2000; 45(5): 294-8. 25.Gardner K, Bennett V. A new erythrocyte membrane-associated protein with calmodulin binding activity: identification and purification. J Biol Chem. 1986; 261: 1339-48. 26.Joshi R, Bennett V. Mapping the domain structure of human erythrocyte adducin. J Biol Chem. 1990; 265: 13130-6. 27.Casari G, Barlassina C, Cusi D, Zagato L, et al. Association of the a-adducin locus with essential hypertension. Hypertension. 1995;25:320-6. 28.Bianchi G, Tripodi G, Casari G, salardi S, et al. Two point mutations within the adducing genes are involved in blood pressure variation. Proc. Nat. Acad. Sci. 1994; 91: 3999-4003. 29.Lin B, Nasir J, Mcdonald H, Graham R, Rommens JM, et al. Genomic organization of the human a-adducin gene and its alternately spliced isoforms. Genomics. 1995; 25: 93-9. 30.Cusi D, Barlassina C, Azzani T, Casari G, et al. Polymorphisms of a-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997; 349: 1353-7 31.Morrison AC, Doris PA, Folsom AR, Nieto FJ, et al. G-protein b3 subunit and a-adducin polymorphisms and risk of subclinical and clinical stroke. Stroke. 2001; 32: 822-9. 32.Cockcroft DW, Gault HM. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16: 31-41. 33.Chuang HY, Lee ML, Chao KY, Wang JD, Hu H. Relationship of blood lead levels to personal hygiene habits in lead battery workers: Taiwan; 1991-1997. Am J Ind Med. 1999; 35(6): 595-603. 34.Wang JG, Staessen JA, Tizzoni L, Brand E, et al. Renal function in relation to three candidate genes. American Journal of Kidney Diseases. 2001; 38(6): 1158-68. 35.Korrick SA, Hunter DJ, Rotnitzky A, Hu H, et al. Lead hypertension in a sample of middle-aged women. Am J Public Health. 1999; 89(3): 330-5. 36.Fuentes RM, Perola M, Nissinen A, Tuomilehto J. ACE gene and physical activity, blood pressure, and hypertension: a population study in Finland. Journal of Applied Physiology. 2002;92(6): 2508-12. 37.Matsubara M, Suzuki M, Fujiwara T, Kikuya M, et al. Angiotensin-converting enzyme I/D polymorphism and hypertension: The Ohasama study. J Hypertens. 2002; 20:01121-6. 38.Kato N, Sugiyama T, Nabika T, Morita H, et al. Lack of association between the a-adducin locus and essential hypertension in the Japanese population. Hypertension. 1998; 31: 730-33. 39.Ishikawa K, Katsuya T, Sato N, Nakata Y, Takami S, et al. No association between a-adducin 460 polymorphism and essential hypertension in a Japanese population. Am J Hypertens. 1998; 11: 502-6. 40.Wang WYS, Adams DJ, Glenn CL, Morris BJ. The Gly460Trp variant of a-adducin is not associated with hypertension in White Anglo-Australians.
|